Page last updated: 2024-10-22

amsacrine and Central Nervous System Neoplasm

amsacrine has been researched along with Central Nervous System Neoplasm in 2 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Research Excerpts

ExcerptRelevanceReference
"with either L1210 cells or Ehrlich ascites tumor cells."1.29ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors. ( Holm, B; Jensen, PB; Sehested, M, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cortes, J1
O'Brien, SM1
Pierce, S1
Keating, MJ1
Freireich, EJ1
Kantarjian, HM1
Holm, B1
Jensen, PB1
Sehested, M1

Other Studies

2 other studies available for amsacrine and Central Nervous System Neoplasm

ArticleYear
The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.
    Blood, 1995, Sep-15, Volume: 86, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocol

1995
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:3

    Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; B

1996